Home Cart Sign in  
Chemical Structure| 222716-34-9 Chemical Structure| 222716-34-9

Structure of SZL P1-41
CAS No.: 222716-34-9

Chemical Structure| 222716-34-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SZL P1-41 is Skp2 inhibitor, selectively suppresses Skp2 E3 ligase activity, but not activity of other SCF complexes.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SZL P1-41

CAS No. :222716-34-9
Formula : C24H24N2O3S
M.W : 420.52
SMILES Code : O=C1C(C2=NC3=CC=CC=C3S2)=COC4=C1C=C(CC)C(O)=C4CN5CCCCC5
MDL No. :MFCD00711481
InChI Key :JKIXLEKBXHMXTN-UHFFFAOYSA-N
Pubchem ID :1286902

Safety of SZL P1-41

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
769-P 20 µM 48 hours Inhibited cell proliferation and clonogenic ability Cell Death Dis. 2022 Jul 13;13(7):606
Caki-1 20.66 µM (IC50) 48 hours Inhibited cell proliferation Cell Death Dis. 2022 Jul 13;13(7):606

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/C nude mice Xenograft model Subcutaneous injection 20 μM 24 days Enhanced sensitivity to TMZ Cancer Cell Int. 2020 Mar 6;20:71
Nude mice C4-2B and 22Rv1 xenograft models Intraperitoneal injection 30 mg/kg Three times per week for 30 days SZL P1-41 treatment decreased tumor proliferation and SKP2:FOXA1 ratios Mol Oncol. 2023 Oct;17(10):2126-2146
Nude mice Xenograft model derived from CAL27-CR cells Intraperitoneal injection 5 mg/kg Every two days Combined with gastrodin significantly delayed tumor growth Cell Death Discov. 2023 Oct 2;9(1):364.
Mice Bleomycin-induced pulmonary fibrosis model Intraperitoneal injection 80 mg/kg Daily for 14 days SZL-P1-41 significantly inhibited the progression of bleomycin-induced pulmonary fibrosis, reduced the accumulation of fibrotic markers such as COL1A1 and fibronectin, and increased p27 levels. Int J Mol Sci. 2018 Feb 6;19(2):474
BALB/C nude mice 769-P xenograft model Intraperitoneal injection 80 mg/kg/day Once daily for 4 weeks Significantly inhibited tumor growth and showed synergistic effects in combination with MLN8237 Cell Death Dis. 2022 Jul 13;13(7):606

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.89mL

2.38mL

1.19mL

23.78mL

4.76mL

2.38mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories